NZSMI

Consumer healthcare products industry body, the New Zealand Self-Medication Industry Association (SMI), endorses the latest communication and stance from the World Health Organization (WHO) in relation to the suitability of ibuprofen as part of the treatment arsenal for the symptoms of COVID-19

Medsafe is asking the Medicines Classification Committee (MCC) to recommend the cough suppressant pholcodine be reclassified as a pharmacist-only medicine.

The reclassification of codeine-containing medicines will go ahead this year after the final objection to the change was determined to be invalid

The lobby group for OTC medicine makers is changing its name to better reflect its purpose

The reclassification of codeine-containing medicines will go ahead this year after the final objection to the change was determined to be invalid. 

The Medicines Classification Committee has determined reclassifying all codeine-containing medicines to prescription-only is justified

The industry body representing medicines manufacturers is concerned a lack of clarity around the upcoming codeine-containing medicines reclassification may result in a situation like the recent dextromethorphan-containing medicines “shambles”

Last week’s surprise change to cough medicine classifications will result in more than 200,000 products being recalled and cost manufacturers hundreds of thousands of dollars, a pharmaceutical industry body says.